Role Of Lncrna In Alzheimer’s Diseases
Article Sidebar
Main Article Content
Abstract
Long noncoding RNA (lncRNA) are a family of RNA molecules with over 200 nucleotides in size. They cannot code for proteins but still have biological activities. lncRNAs are abundantly expressed in the pathogenic process of neurological diseases like Alzheimer’s. The lncRNA EBF3-AS is more expressed in the brains of older Alzheimer's disease patients called late onset Alzheimer’s disease. NAT-Rad18, a lncRNA over synthesized in specific areas of the brain in AD rats. The lncRNA n336694 targets miR-106b which increases its expression. MiR-106b leads to apoptosis markers in cells. oxidative stress-induced injury to the neurons is caused by the lncRNA SOX21-AS1. The lncRNA-ATB is involved in AD pathophysiology and reducing its expression helps with oxidative stress-induced injury. lncRNA MEG3 inhibits inflammatory injury and oxidative stress in individuals suffering from AD. The increase of lncRNA 17A in cerebral tissues of AD patients affects Aβ secretion. BACE1-AS suppression reduces Aβ and BACE1 levels and inhibits tau protein phosphorylation (3). The lncRNA BC200, also known as BCYRN1 upregulates Aβ production through BACE1 modulation which leads to AD pathogenesis. NEAT1 regulates the miR-124/BACE1 axis and plays a role in AD development. Reduced SORL1 expression increases neurotoxic Aβ formation in AD brains. LRP1-AS negatively regulates systemic Aβ clearance during AD progression. GAS5 regulates insulin signaling, neuronal survival, tau phosphorylation, and neuroinflammation. MAGI2-AS3-miR-374b-5p axis modulates neuroinflammation and neurotoxicity caused by Aβ fragment. Upregulation of WT1-AS inhibits the miR-375/SIX4 axis, OSI, and neuronal apoptosis in AD. BDNF-AS is found to be important in AD though the mechanism has yet to be determined. This review study aims to enhance comprehension of the disease progression of Alzheimer's disease (AD) in relation to various long non-coding RNAs (lncRNA).
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Asadi, M. R., Hassani, M., Kiani, S., Sabaie, H., Moslehian, M. S., Kazemi, M., Ghafouri-Fard, S., Taheri, M., & Rezazadeh, M. (2021). The perspective of dysregulated lncrnas in alzheimer’s disease: A systematic scoping review. Frontiers in Aging Neuroscience, 13.
https://doi.org/10.3389/fnagi.2021.709568
Bhattacharyya, N., Pandey, V., Bhattacharyya, M., & Dey, A. (2021). Regulatory role of long non coding RNAs (lncRNAs) in neurological disorders: From novel biomarkers to promising therapeutic strategies. Asian journal of pharmaceutical sciences, 16(5), 533–550.
https://doi.org/10.1016/j.ajps.2021.02.006
Brooks, P. J. (2002). DNA repair in neural cells: Basic science and clinical implications. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 509(1–2), 93–108. https://doi.org/10.1016/s0027-5107(02)00222-1
Canseco-Rodriguez, A., Masola, V., Aliperti, V., Meseguer-Beltran, M., Donizetti, A., & Sanchez-Perez, A. M. (2022). Long non-coding RNAS, extracellular vesicles and inflammation in alzheimer’s disease. International Journal of Molecular Sciences, 23(21), 13171. https://doi.org/10.3390/ijms232113171
Dong, L. X., Zhang, Y. Y., Bao, H. L., Liu, Y., Zhang, G. W., & An, F. M. (2021). LncRNA NEAT1 promotes Alzheimer's disease by down regulating micro-27a-3p. American journal of translational research, 13(8), 8885–8896.
Gao, Y., Zhang, N., Lv, C., Li, N., Li, X., & Li, W. (2020). lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 77(1), 85–98. https://doi.org/10.3233/JAD-191303
Gu, C., Chen, C., Wu, R., Dong, T., Hu, X., Yao, Y., & Zhang, Y. (2018). Long noncoding RNA EBF3-as promotes neuron apoptosis in alzheimer’s disease. DNA and Cell Biology, 37(3), 220–226. https://doi.org/10.1089/dna.2017.4012
Gu, R., Liu, R., Wang, L., Tang, M., Li, S. R., & Hu, X. (2021). LncRNA RPPH1 attenuates Aβ25-35-induced endoplasmic reticulum stress and apoptosis in SH-SY5Y cells via miR-326/PKM2. The International journal of neuroscience, 131(5), 425–432. https://doi.org/10.1080/00207454.2020.1746307
Hampel, H., Lista, S., & Khachaturian, Z. S. (2012). Development of biomarkers to chart all alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot. Alzheimer’s & Dementia, 8(4), 312–336. https://doi.org/10.1016/j.jalz.2012.05.2116
He, W., Chi, S., Jin, X., Lu, J., Zheng, W., Yan, J., & Zhang, D. (2020). Long non-coding RNA BACE1-as modulates isoflurane-induced neurotoxicity to alzheimer’s disease through sponging mir-214-3P. Neurochemical Research, 45(10), 2324–2335. https://doi.org/10.1007/s11064-020-03091-2
https://doi.org/10.1016/j.biopha.2017.05.060
Huang, W., Li, Z., Zhao, L., & Zhao, W. (2017). Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer’s disease via modulating the expression of mir-106b. Biomedicine & Pharmacotherapy, 92, 46–57.
Khodayi, M., Khalaj-Kondori, M., Hoseinpour Feizi, M. A., Jabarpour Bonyadi, M., & Talebi, M. (2022). Plasma lncRNA profiling identified BC200 and NEAT1 lncRNAs as potential blood-based biomarkers for late-onset Alzheimer's disease. EXCLI journal, 21, 772–785. https://doi.org/10.17179/excli2022-4764
Lan, Z., Chen, Y., Jin, J., Xu, Y., & Zhu, X. (2022). Long non-coding RNA: Insight into mechanisms of alzheimer’s disease. Frontiers in Molecular Neuroscience, 14. https://doi.org/10.3389/fnmol.2021.821002
Lee, W.-P., Choi, S. H., Shea, M. G., Cheng, P.-L., Dombroski, B. A., Pitsillides, A. N., Heard-Costa, N. L., Wang, H., Bulekova, K., Kuzma, A. B., Leung, Y. Y., Farrell, J. J., Lin, H., Naj, A., Blue, E. E., Nusetor, F., Wang, D., Boerwinkle, E., Bush, W. S., … Peloso, G. M. (2023). Association of Common and Rare Variants with Alzheimer’s Disease in over 13,000 Diverse Individuals with Whole-Genome Sequencing from the Alzheimer’s Disease Sequencing Project.
https://doi.org/10.1101/2023.09.01.23294953
Li, D., Zhang, J., Li, X., Chen, Y., Yu, F., & Liu, Q. (2021). Insights into lncRNAs in Alzheimer's disease mechanisms. RNA biology, 18(7), 1037–1047. https://doi.org/10.1080/15476286.2020.1788848
Li, L., Xu, Y., Zhao, M., & Gao, Z. (2020). Neuro-protective roles of long non-coding RNA MALAT1 in Alzheimer's disease with the involvement of the microRNA-30b/CNR1 network and the following PI3K/AKT activation. Experimental and molecular pathology, 117, 104545.
https://doi.org/10.1016/j.yexmp.2020.104545
Muhs, A., Lohmann, S., Hickman, D., Pihlgren, M., Nagel-Steger, L., Machaidze, G., Mason, J., Bechinger, B., Pfeifer, A., & Nicolau*, C. (2006). O1–06–06: Improved memory capacity of amyloid precursor protein transgenic mice through passive administration of a monoclonal antibody inducing a conformational shift of amyloid–beta. Alzheimer’s & Dementia, 2(3S_Part_1).
https://doi.org/10.1016/j.jalz.2006.05.066
Parenti, R., Paratore, S., Torrisi, A., & Cavallaro, S. (2007). A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis. The European journal of neuroscience, 26(9), 2444–2457. https://doi.org/10.1111/j.1460-9568.2007.05864.x
Wang, J., Zhou, T., Wang, T., & Wang, B. (2018). Suppression of lncRNA-ATB prevents amyloid-β-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 108, 707–715.
https://doi.org/10.1016/j.biopha.2018.08.155
Wang, Q., Ge, X., Zhang, J., & Chen, L. (2020). Effect of lncRNA WT1-AS regulating WT1 on oxidative stress injury and apoptosis of neurons in Alzheimer's disease via inhibition of the miR-375/SIX4 axis. Aging, 12(23), 23974–23995.
Wang, X., Zhang, M., & Liu, H. (2019). LNCRNA17A regulates autophagy and apoptosis of SH-SY5Y cell line as anin vitromodel for alzheimer’s disease. Bioscience, Biotechnology, and Biochemistry, 83(4), 609–621. https://doi.org/10.1080/09168451.2018.1562874
Xu, W., Li, K., Fan, Q., Zong, B., & Han, L. (2020). Knockdown of long non-coding RNA SOX21-AS1 attenuates amyloid-β-induced neuronal damage by sponging miR-107. Bioscience reports, 40(3), BSR20194295. https://doi.org/10.1042/BSR20194295
Yue, D., Guanqun, G., Jingxin, L., Sen, S., Shuang, L., Yan, S., Minxue, Z., Ping, Y., Chong, L., Zhuobo, Z., & Yafen, W. (2020). Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124. Cell biology international, 44(2), 630–636. https://doi.org/10.1002/cbin.11263
Zhang, Y., Zhao, Y., Ao, X., Yu, W., Zhang, L., Wang, Y., & Chang, W. (2021). The role of non-coding RNAS in alzheimer’s disease: From regulated mechanism to therapeutic targets and diagnostic biomarkers. Frontiers in Aging Neuroscience, 13. https://doi.org/10.3389/fnagi.2021.654978